Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage.

@article{Mercier2010UseOC,
  title={Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage.},
  author={Fr{\'e}d{\'e}ric Jean Mercier and Marie Pierre Bonnet},
  journal={Current opinion in anaesthesiology},
  year={2010},
  volume={23 3},
  pages={
          310-6
        }
}
PURPOSE OF REVIEW To guide the optimal use of blood products and to clarify the indications for prohemostatic drugs in obstetric hemorrhage. RECENT FINDINGS The literature emphasizes the usefulness of transfusing packed red blood cells, fresh frozen plasma and platelets earlier and in defined ratios to prevent dilutional coagulopathy during obstetric hemorrhage. The value of fibrinogen concentrate and prohemostatic drugs such as tranexamic acid and recombinant factor VIIa is also pointed out… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 20 CITATIONS

Can coagulopathy in post-partum hemorrhage predict maternal morbidity?

  • The journal of obstetrics and gynaecology research
  • 2016
VIEW 15 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

Identification and Management of Obstetric Hemorrhage.

  • Anesthesiology clinics
  • 2017
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED